Here - EWMA 2013

ORAL PRESENTATIONS
KEY SESSION: WHAT IS GOOD EVIDENCE IN WOUND CARE AND HOW DO WE GENERATE IT?
160
Key Session: What is Good Evidence in Wound Care and How do We Generate it?
AN UPDATE ON EVIDENCE BASED PRACTICE IN WOUND CARE
– WHERE ARE WE NOW
Andrea Nelson 1
1 University of Leeds (Leeds, United Kingdom).
The concept of Evidence Based Practice (EBP) has been described in the literature for
two decades, initially as evidence-based medicine(1). It requires clinicians to make
conscientious decisions based not only on the available evidence but also on patient
characteristics, situations, available resources and preferences. The extent to which the
Wound Care community has adopted an Evidence based approach to care has been
limited by both the relative paucity of high quality evidence from well designed and
conducted studies (the evidence gap), but also by the rhetoric that states that it is not a
relevant model for wound care (the relevance gap).
This paper will address both the evidence gap and the relevance gap. In addressing
progress towards attaining more evidence of a higher quality, it will describe some
suggested metrics for a mature, evidence-based discipline, in order to initiate discussion
regarding how wound care has fared. This includes the availability of well reported and
conducted research papers, and the extent to which they meet patient and clinician
needs. In addressing the relevance gap it will address some of the concerns regarding
the EBP model.
Actions for researchers, clinicians, journal editors and funders of research that would
increase the availability of high quality evidence for EBP will be proposed.
1. JAMA. 1992;268(17):2420-2425. doi:10.1001/jama.1992.03490170092032
161
Key Session: What is Good Evidence in Wound Care and How do We Generate it?
What kind of evidence do we need for investment in e-health?
Kristian Kidholm 1
1 Odense University Hospital (Odense, Denmark).
E-health could potentially solve many of the challenges faced by the healthcare sectors
in Europe. However, evidence of the outcomes of these technologies is need by decision
makers to assist them in choosing the most efficient and cost-effective technologies.
Therefore in 2009 the European Commission initiated the development of a framework
for assessing e-health applications, based on the users’ need for information for decision
making. As a result, the Model for ASsessment of Telemedicine applications (MAST) was
developed through systematic literature studies and workshops with users and
stakeholders of telemedicine.
Based on the workshops a three-element model was developed, including: (i) preceding
considerations, (ii) multidisciplinary assessment, and (iii) transferability assessment. In
the multidisciplinary assessment, the outcomes of telemedicine applications comprise
seven domains, based on the domains in the EUnetHTA model.
MAST is now the most widely used framework for assessment of e-health applications in
Europe. More than 30 studies of e-health including about 30.000 patients are ongoing or
planned based on MAST.
In the presentation information about the content and use of MAST will be given
including links to information about data collection, outcome measures and guidelines for
reporting of results.
100